Prognostic values of thyroid tumours

Bosnian Journal of Basic Medical Sciences

Volumn 9, Issue 2, 2009, Pages 111-119

  Manxhuka Kerliu, Suzana ^a   Devolli Disha, Emine ^a   Gerxhaliu, Arsim ^a   Ahmetaj, Halil ^a   Baruti, Arijeta ^a   Loxha, Sadushe ^a   Thaqi, Hajdin ^a  

^a UNIVERSITY OF PRISHTINA   (Serbia)

Author keywords

Histopathology; Prognostic values; Thyroid; Thyroid tumours

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HUMAN; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SEX DIFFERENCE; SURVIVAL RATE; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; SEX FACTORS; SURVIVAL RATE; THYROID NEOPLASMS;

EID: 67649394431     PISSN: 15128601     EISSN: None     Source Type: Journal    
DOI: 10.17305/bjbms.2009.2829     Document Type: Article

References (56)

1. Liska J., Altanerova V., Galbavy S. et al. Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer. Endocr. Regul. 2005; 39(3)73-83.
2. Malchoff C.D., Malchoff D.M. The genetics of hereditary nonmedullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 2002;87(6)2455-2459.
3. Dǎnilǎ R., Popovic R., Grigorovici A., Ionescu L., Timofte D., Lefter L., Boiculesei L.V., Ungureanu M.C., Dragomir C. The impact of patient and tumor related prognostic factors on survival in non-medullary differentiated thyroid cancer. A study of 125 cases. Rev. Med. Chir. Soc. Med. Nat. Iasi. 2007; 111(4):940-945..
4. Jung T.S., Kim T.Y., Kim K.W., Oh Y.L., Park do J., Cho B.Y., Shong Y.K., Kim W.B., Park Y.J., Jung J.H., Chung J.H. Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma. Endocr. J. 2007; 54(2)265-274.
5. Mazzaferri E.L., Kloos R.T. Current approaches to primary therapy for papillary and follicular thyroid cancer. J. Clin. Endocrinol. Metab. 2001; 86:1447-1463.
6. Mazzaferri E.L., Robbins R.J., Spencer C.A. et al. A consensus report of the role of thyroglobulin as a monitoring method for low risk patients with papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 2003; 88(4)143 3-1441.
7. Ghelase F.,Bistriceanu M.,Georgescu I.,Ghelase S.M.,Gǎban V.,Mǎrgǎritescu D.,Georgescu E.,Bratiloveanu T.,Cioarǎ F.,Pleşea E. Diff erentiated thyroid carcinoma. Diagnosis and therapeutic aspects. Chirurgia (Bucur). 2007; 1O2(3):289-295.
8. Kakudo K., Tang W., Ito Y., et al. Papillary carcinoma of the thyroid in Japan: subclassification of common type and identifi cation of low risk group. J. Clin. Path. 2004; 57:1041-1046.
9. Falvo L., Catania A., D'Andrea V., Marzullo A. et al. Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma. Ann. Surg. 2005; 241 (4):640-644.
10. Vini L., Hyer S., Pratt B., et al. Good prognosis in thyroid cancer found incidentally at surgery for thyrotoxicosis. Postgrad. Med. J. 1999;75(881):169-17O.
11. Lim D.J., Baek K.H., Lee Y.S., Park W.C., Kim M.K., Kang M.I., Jeon H.M., Lee J.M., Yun-Cha B., Lee K.W., Son H.Y., Kang S.K. Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma. Thyroid. 2007; 17(9):883-888.
12. Wada N., Hasegawa S., Masudo Y., Hirakawa S., Matsuzu K., Suganuma N., Nakayama H., Rino Y., Imada T. Clinical outcome by AMES risk definition in Japanese differentiated thyroid carcinoma. Asian J. Surg. 2007; 30(2):1O2-1O7.
13. Demidchik Iu.E., Fridman M.V., Pisarenko A.M. Anaplastic thyroid carcinoma: diagnosis treatment and prognosis. Vopr. Onkol. 2007;53(l):37-45
14. Sherman S.I. Anaplastic carcinoma: clinical aspects. In: Wartofsky L. ed. Thyroid Cancer: a comprehensive guide to clinical management. Totowa: Humana Press. 1999; 319-325.
15. Pelizzo M.R., Boschin I.M., Toniato A., Piotto A., Pagetta C., Gross M.D., Al-Nahhas A., Rubello D. Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients. Clin. Nucl. Med. 2007; 32(6) :440-444.
16. Sherman S.I. Thyroid carcinoma. Lancet. 2003; 8; 361(9356):501-511.
17. Bai Y., Kakudo K., Li Y., Liu Z., Ozaki T., Ito Y., Kihara M., Miyauchi A. Subclassification of non-solid-type papillary thyroid carcinoma identification of high risk group in common type. Cancer Sci. 2008; 99(10):1908-1915.
18. Gulcelik M.A., Gulcelik N.E., Kuru B., Camlibel M., Alagol H. Prognostic factors determining survival in differentiated thyroid cancer. J. Surg. Oncol. 2007; 96(7):598-604.
19. Shaha A.R. TNM classification of thyroid carcinoma. World J.Surg. 2007; 31 (5):879-887.
20. Kim T.Y., Hong S.J., Kim J.M., Gu Kim W., Gong G., Ryu J.S., Kim W.B., Yun S.C., Shong Y.K. Prognostic parameters for recurrence of papillary thyroid microcarcinoma. BMC. Cancer. 2008; 14; 8 296.
21. Jacquot-Laperriére S., Timoshenko A.P., Dumollard J.M., Peoc'h M., Estour B., Martin C., Prades J.M. Papillary thyroid microcarcinoma:incidence and prognostic factors. Eur. Arch. Otorhinolaryngol. 2007; 264(8):935-939.
22. Besic N., Pilko G., Petric R., Hocevar M., Zgajnar J. Papillary thyroid microcarcinoma: incidence and prognostic factors. J. Surg. Oncol. 2008; 1;97(3):221-225
23. Pelizzo M.R., Merante Boschin I., Toniato A., Pagetta C., Casal Ide E., Mian C., Rubello D. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma. Minerva Endocrinol. 2008; 33 (4):359-379.
24. Yuksel O., Kurukahvecioglu O., Ege B., Ekinci O., Aydin A., Poyraz A., Tezel E., Taneri F. The relation between pure papillary and follicular variant in papillary thyroid carcinoma. Endocr. Regul. 2008;42(l):29-33.
25. Soyluk O., Selcukbiricik F., Erbil Y., Bozbora A., Kapran Y., Ozbey N. Prognostic factors in patients with papillary thyroid carcinoma. J. Endocrinol. Invest. 2008; 31(11):1032-1037.
26. Schweppe R.E., Kerege A.A., French J.D., Sharma V., Grzywa R.L., Haugen B.R. Inhibition of SRC with ASD0530 reveals the SRCfocal adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancers. J. Clin. Endocrinol. Metab. tab.2009; 17.
27. Demidchik Iu.E., Fridman M.V., Pisarenko A.M. Anaplastic thyroid carcinoma: diagnosis treatment and prognosis. Vopr. Onkol. 2007; 53(1):37-45.
28. Ito Y., Hirokawa M., Higashiyama T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Kuma K., Miyauchi A. Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination. World J. Surg. 2007; 31(7):1417-1424.
29. De Falco M., Oliva G., Ragusa M., Misso C. Jr., Parmeggiani D., Sperlongano P., Calzolari F., Puxeddu E., Misso C., Marzano L.A., Barbarisi A., Parmeggiani U., Avenia N. Surgical treatment of differentiated thyroid carcinoma: a retrospective study. G. Chir. 2008; 29(4):152-158.
30. Miccoli P., Minuto MN., Ugolini C., Molinaro E., Basolo F., Berti P., Pinchera A., Elisei R. Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer. Endocr. Relat. Cancer. 2007; 14(4):1099-1105.
31. Shaha A.R., Loree T.R., Shah J.P. Intermediate-risk group for differentiated carcinoma of the thyroid. Surg. 1994; 116:1036-1041.
32. Shaha A.R., Shah J.P., Loree T.R. Risk group stratifi cation and prognostic factors in papillary carcinoma of thyroid. Ann. Surg. Oncol. 1996; (3): 534-538.
33. Shaha A.R., Shah J.P., Loree T. R. Patterns of failure in differentiated carcinoma of the thyroid based on risk groups. Head&Neck. 1998; 20(1):26-30.
34. Toniato A., Boschin I., Casara D., Mazzarotto R., Rubello D., Pelizzo M. Papillary thyroid carcinoma: factors infl uencing recurrence and survival. Ann. Surg. Oncol. 2008; 15(5):1518-1522.
35. Levi F., Randimbison L., Te V.C. & La Vecchia C. Thyroid cancer in Vaud, Switzerland: an update. Thyroid. 2000; (12): 163-168.
36. Salvesen H., Njolstad P.R., Akslen L.A. et al. Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. Eur. J. Surg. 1992; 158: 583-589.
37. Lerch H., Schober O. Kuwert T. & Saur H.B. Survival of differentiated thyroid carcinoma studied in 500 patients. J. Clin. Oncol. 1997:15:2067-2075.
38. Cady B. Beyond risk groups - a new look at differentiated thyroid cancer. Surgery. 1998; 124:947-957.
39. Cady B., Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988; 104:947-953.
40. Miccoli P., Minuto M.N., Ugolini C., Panicucci E., Massi M., Berti P., Basolo F. Papillary thyroid cancer: pathological parameters as prognostic factors in different classes of age. Otolaryngol. Head&Neck Surg. 2008; 138(2)200-203.
41. Pelizzo M.R., Merante Boschin I., Toniato A., Piotto A., Bernante P., Pagetta C., Casal Ide E., Mazzarotto R., Casara D., Rubello D. Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data. Minerva Chir. 2007;62(5)315-325.
42. Passler C., Scheuba C., Prager G. et al. Prognostic factors of papillary and follicular thyroid cancer: diff erences in an iodine-replete endemic goiter region. Endocrine Rel. Cancer. 2004; 11:131-139.
43. Carcangiu M.L., Bianchi S. Diffuse sclerosing variant of papillary thyroid carcinoma: clinico-pathologic study of 15. Am. J. Surg. Path. 1989; 13:1041-1049.
44. Carcangiu M.L., Zampi G., Pupi A., Castagnoli A., Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 1985; 55: 805-828.
45. De Groot L.J., Kaplan E.L., McCormick M. & Straus F. Natural history, treatment, and course of papillary thyroid carcinoma. J. Clin. Endocrinol. & Metab. 1990; 71:414-424.
46. Hay I.D. Papillary thyroid carcinoma. Endocrinol. & Metab. Clin. of North America. 1990; 9: 545-576.
47. Hay I.D., Bergstralh E.J., Goellner J.R., et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1997 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993; 114:1050-1058.
48. Loh K.C., Greenspan F.S., Gee L., Miller T.R., Yeo P.P.B.Pathological tumour-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J. Clin. Endocrinol. Metab. 1997; 82: 3553-3562.
49. Roti E., Rossi R., Trasforini G. et al. Clinical and histological characteristics of papillary thyroid microcarcinomas: Results of a retrospective study in 243 patients. J. Clin. Endocrinol.Metab. 2006; 91 (6): 2171-2178.
50. Cady B., Sedgwick M.D., Meissner W.A. et al. Risk factor analysis in differentiated thyroid cancer. Cancer. 1979; 43: 810-820.
51. Gilliland F.D., Hunt W.C., Morris D.M., Key C.R. Prognostic factors for thyroid carcinoma. Population-based study of 15 698 cases from Surveillance, Epidemiology and End results (SEER) program 1973-1991. Cancer. 1997;79(3):564-573.
52. Pulcrano M., Boukheris H., Talbot M., Caillou B., Dupuy C., Virion A., De Vathaire F., Schlumberger M. Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification. Thyroid 2007; 17 (7)639-646
53. Showalter T.N., Siegel B.A., Moley J.F., Baranski T.J., Grigsby P.W. Prognostic factors in patients with well-differentaiated thyroid cancer presenting with pulmonary metastasis. Cancer Biother. Radiopharm. 2008; 23(5):655-659.
54. Kuo S.F., Chao T.C., Hsueh C., Chuang W.Y., Yang C.H., Lin J.D. Prognosis and risk stratifi cation in young papillary thyroid carcinoma patients. Endocr. J. 2008; 55(2):269-275.
55. Zhang Q., Yang C.S., Guo Z.M., Zeng Z.Y., Yang A.K., Lai F.Y. Prognostic factors of medullary thyroid carcinoma. Zhonghua Er. Bi. Yan. Hou. Tou. Jing. Wai. Ke. Za. Zhi. 2008; 43(12):939-943.
56. Leggett M.D., Chen S.L., Schneider P.D., Martinez S.R. Prognostic values of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma. Ann. Surg. Oncol. 2008; 15(9)2493-2499.